Search

Author/Creator Masters, Gregory

1. A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer. Issue 1 (January 2015)

Authors:
Lilenbaum, Rogerio; Samuels, Michael; Wang, Xiaofei; Kong, Feng Ming; Jänne, Pasi A.; Masters, Gregory; Katragadda, Sreedhar; Hodgson, Lydia; Bogart, Jeffrey; Bradley, Jeffrey; Vokes, Everett
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 1(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG). Issue 1 (January 2015)

Authors:
Lilenbaum, Rogerio; Samuels, Michael; Wang, Xiaofei; Kong, Feng Ming; Jänne, Pasi A.; Masters, Gregory; Katragadda, Sreedhar; Hodgson, Lydia; Bogart, Jeffrey; Bradley, Jeffrey; Vokes, Everett
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 1(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study. (11th March 2021)

Authors:
Varlotto, John M.; Sun, Zhuoxin; Ky, Bonnie; Upshaw, Jenica; Katz, Sharyn I.; Fitzgerald, Thomas J.; Wakelee, Heather; Diehn, Maximilian; Mankoff, David A.; Lovely, Christine; Belani, Chandra; Oettel, Kurt; Masters, Gregory; Ramalingam, Suresh; Pennell, Nathan A.
Journal:
Oncologist
Issue:
Volume 26:Number 6(2021)
Page Start:
523
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A Review of Immunotherapy for Stage III and Metastatic Non‐Small Cell Lung Cancer and the Rationale for the ECOG‐ACRIN EA5181 Study. (11th March 2021)

Authors:
Varlotto, John M.; Sun, Zhuoxin; Ky, Bonnie; Upshaw, Jenica; Katz, Sharyn I.; Fitzgerald, Thomas J.; Wakelee, Heather; Diehn, Maximilian; Mankoff, David A.; Lovely, Christine; Belani, Chandra; Oettel, Kurt; Masters, Gregory; Ramalingam, Suresh; Pennell, Nathan A.
Journal:
Oncologist
Issue:
Volume 26:Number 6(2021)
Page Start:
523
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study. Issue 1 (January 2018)

Authors:
Herbst, Roy S; Redman, Mary W; Kim, Edward S; Semrad, Thomas J; Bazhenova, Lyudmila; Masters, Gregory; Oettel, Kurt; Guaglianone, Perry; Reynolds, Christopher; Karnad, Anand; Arnold, Susanne M; Varella-Garcia, Marileila; Moon, James; Mack, Philip C; Blanke, Charles D; Hirsch, Fred R; Kelly, Karen...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 1(2018)
Page Start:
101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Issue 2 (February 2015)

Authors:
Bradley, Jeffrey D; Paulus, Rebecca; Komaki, Ritsuko; Masters, Gregory; Blumenschein, George; Schild, Steven; Bogart, Jeffrey; Hu, Chen; Forster, Kenneth; Magliocco, Anthony; Kavadi, Vivek; Garces, Yolanda I; Narayan, Samir; Iyengar, Puneeth; Robinson, Cliff; Wynn, Raymond B; Koprowski, Christoph...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Issue 2 (February 2015)

Authors:
Bradley, Jeffrey D; Paulus, Rebecca; Komaki, Ritsuko; Masters, Gregory; Blumenschein, George; Schild, Steven; Bogart, Jeffrey; Hu, Chen; Forster, Kenneth; Magliocco, Anthony; Kavadi, Vivek; Garces, Yolanda I; Narayan, Samir; Iyengar, Puneeth; Robinson, Cliff; Wynn, Raymond B; Koprowski, Christoph...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. Issue 9 (20th March 2021)

Authors:
Hanna, Nasser H.; Robinson, Andrew G.; Temin, Sarah; Baker, Sherman; Brahmer, Julie R.; Ellis, Peter M.; Gaspar, Laurie E.; Haddad, Rami Y.; Hesketh, Paul J.; Jain, Dharamvir; Jaiyesimi, Ishmael; Johnson, David H.; Leighl, Natasha B.; Moffitt, Pamela R.; Phillips, Tanyanika; Riely, Gregory J.; Ro...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 9(2021)
Page Start:
1040
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Issue 5 (10th February 2023)

Authors:
Owen, Dwight H.; Singh, Navneet; Ismaila, Nofisat; Blanchard, Elizabeth; Celano, Paul; Florez, Narjust; Jain, Dharamvir; Leighl, Natasha B.; Mamdani, Hirva; Masters, Gregory; Moffitt, Pamela R.; Naidoo, Jarushka; Phillips, Tanyanika; Riely, Gregory J.; Robinson, Andrew G.; Schenk, Erin; Schneider...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 5(2023)
Page Start:
e10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline. Issue 28 (1st October 2022)

Authors:
Singh, Navneet; Temin, Sarah; Baker, Sherman; Blanchard, Elizabeth; Brahmer, Julie R.; Celano, Paul; Duma, Narjust; Ellis, Peter M.; Elkins, Ivy B.; Haddad, Rami Y.; Hesketh, Paul J.; Jain, Dharamvir; Johnson, David H.; Leighl, Natasha B.; Mamdani, Hirva; Masters, Gregory; Moffitt, Pamela R.; Phi...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 28(2022)
Page Start:
3310
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗